ImmunoPrecise Antibodies Ltd.
Ownership
Ownership Structure
Who owns ImmunoPrecise Antibodies Ltd. (HYFT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.0% of the shares are freely tradable; institutional investors hold 10.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Ingalls & Snyder LLC | 6.19 | 2,907,040 | +6.5 | 03/31/2026 |
| Susquehanna International Group, LLP | 1.14 | 534,016 | +0.6 | 03/31/2026 |
| Renaissance Technologies Corp | 0.49 | 232,480 | -2.8 | 03/31/2026 |
| XTX Topco Ltd | 0.37 | 172,547 | +111.1 | 03/31/2026 |
| Jane Street Group LLC | 0.27 | 126,552 | -21.5 | 03/31/2026 |
| Bank of Montreal | 0.17 | 77,947 | +11.4 | 06/30/2026 |
| BMO Capital Markets Corp. | 0.15 | 69,947 | +27.8 | 03/31/2026 |
| Bridgeway Capital Management, LLC | 0.11 | 50,000 | +0.0 | 03/31/2026 |
| Virtu Financial LLC | 0.10 | 48,928 | +76.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Micro-Cap ETF | 0.31 | 143,766 | -1.9 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.